Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Allergy Diagnostics Market Size to Reach USD 12.45 Billion in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

14 Feb, 2023, 17:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Feb. 14, 2023 /PRNewswire/ -- The allergy diagnostics market size reached USD 4.80 Billion in 2021 and is expected to register a CAGR of 11.1% during the forecast period, according to latest analysis by Emergen Research. One key factor driving market revenue growth is growing funding and investments for allergy diagnostics. For instance, on 20 December 2022, Nectar, a provider of allergy testing and treatment, increased its total equity capital to more than USD 24 million with a USD 16.5 million Series A fundraising round headed by Harmony Partners. Furthermore, on 7 December 2020, in order to provide quick and accurate allergy testing so doctors can test and treat more patients in a single clinic visit, Kenota Health Inc., an innovative Canadian medical technology startup, raised USD 11 million in investment.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1566

Drivers:

Demand for allergy diagnostics has significantly increased over the years owing to high prevalence of allergic diseases. For instance, according to recent studies, between 1.1 and 10.8% of the world's population is estimated to have a food allergy, and prevalence of these allergies continues to rise. Approximately 32 million Americans claim to have a food allergy, and every year, about 200,000 individuals require emergency medical attention owing to a food allergy. In the United States, one in every 13 children has a food allergy, making them particularly prevalent in younger generations.

Restraints:

There are numerous issues and difficulties facing the allergy diagnostics industry. Inadequate awareness and unreliable tests for allergy testing are one such factor. For instance, although oral immunotherapy (OIT) has shown promise in the treatment of food allergies, it is not currently a standard therapy. However, trials are being conducted to ascertain OIT's safety and efficacy. Many alternative therapists may give allergy as well as food intolerance tests that are not supported by scientific data. These tests are distinguished by a scarcity of supporting scientific data, a weak connection with tests that are grounded in evidence, and inconsistent results when performed on the same subject many times.

Growth Projections:

The allergy diagnostics market is expected to register a CAGR of 11.1% over the forecast period and revenue is projected to increase from USD 4.80 Billion in 2021 to USD 12.45 Billion in 2030. Currently, the application of mobile health technology has seen a rise, which is aiding in market revenue growth. Individuals with dermatological allergic illnesses such as contact dermatitis, atopic dermatitis, and chronic urticaria benefit greatly from the use of mobile health technology. Applications can be helpful to increase treatment regimen adherence, track symptoms, facilitate doctor-patient interactions, including patients in support groups, and carrying out clinical studies once a diagnosis has been made. Furthermore, on 22 August 2022, LifeMD, Inc., a fast expanding direct-to-patient telehealth business, announced that Allergenis, a provider of predictive data analytics with a focus on the identification and treatment of life-threatening food allergies, has joined forces with its allergy telemedicine subsidiary cleared. More collaborations as stated above, coming up in the market is expected to drive demand for allergy diagnostics.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1566

Current Trends and Innovations:

The allergy diagnostics industry is undergoing gradual change as a result of new technology and innovations. For instance, on 10 June 2022, the company Oncologica announced the availability of Allergyfocus, a novel antibody allergy test that swiftly and precisely identifies 99% of all known types of allergies. Users learn about the typical, worldwide allergens to which their bodies are sensitive via this new Allergyfocus test. In-depth, personalized antibody profiles of a patient's allergy triggers are provided for accurate diagnosis. Additionally, pre-registration testing is being done on systems that automatically interpret skin allergy test results. Making it accessible for widespread usage might demonstrate to be a significant value in a world where allergic disorders, such as asthma, afflict a growing portion of the populace.

Strategic Initiatives:

Major companies included in the market report are Thermo Fisher Scientific Inc., Danaher, Minaris Medical America, Inc., Siemens Healthcare GmbH, Eurofins Scientific, Euroimmun Medizinische Labordiagnostika AG, Biomérieux SA, Stallergenes Greer, Neogen Corporation, and Omega Diagnostics Group PLC.

  • On 16 July 2021, Reacta, a company on track to revolutionize the market for food allergy diagnostics, raised USD 3.5 million in a fundraising round headed by Praetura Ventures with additional funding from the Development Bank of Wales.
  • On 23 November 2020, Bio-Me, a provider of microbiome diagnostics, and Siolta Therapeutics reported that they have signed a partnership and marketing agreement. According to the agreement, Siolta will help Bio-Me create a quick, in-depth, and thorough diagnostic test for newborns who are at risk of developing allergies and asthma by providing samples and insights on important criteria.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/allergy-diagnostics-market

Scope of Research

Report Details

Outcome

Market size in 2021

USD 4.80 Billion

CAGR (2022–2030)

11.1 %

Revenue forecast to 2030

USD 12.45 Billion

Base year for estimation

2021

Historical data

2021–2030

Forecast period

2022–2030

Quantitative units

Revenue in USD Million and CAGR in % from 2022 to 2030.

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product & service, allergen, test type, end-use, and region

Regional scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, U.A.E., Israel, and Rest of MEA.

Key companies profiled

Thermo Fisher Scientific Inc., Danaher, Minaris Medical America, Inc., Siemens Healthcare GmbH, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, BIOMÉRIEUX SA, Stallergenes Greer, Neogen Corporation, and Omega Diagnostics Group PLC

Customization scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1566

Emergen Research has segmented the allergy diagnostics market on the basis of product & service, allergen, test type, end-use, and region:

  • Product & Service Outlook (Revenue, USD Billion; 2019–2030)
    • Consumables
    • Instruments
  • Immunoassay Analyzers
  • ELISA Analyzers
  • Luminometers
  • Others
    • Services
  • Allergen Outlook (Revenue, USD Billion; 2019–2030)
  •  
    • Inhaled Allergens
    • Food Allergens
    • Drug Allergens
    • Others
  • Test Type Outlook (Revenue, USD Billion; 2019–2030)
    • In Vivo Tests
      • Skin Prick Tests
      • Patch Tests
      • Others
  •  
    • In Vitro Tests
  • End-Use Outlook (Revenue, USD Billion; 2019–2030)
    • Diagnostics Laboratories
    • Hospital-based Laboratories
    • Academic Research Institutes
    • Others
  • Regional Outlook (Revenue, USD Billion, 2019 - 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Africa
      • Rest of Middle East

Latest Research Reports Published by Emergen Research:

Enterprise Information Archiving Market, By Type (Content Type, Services), By Deployment Mode, By Vertical, (Government and Defense, Banking and Financial Services, Retail and E-commerce, Other Verticals), By Region Forecast to 2032

Veterinary Anesthesia Equipment Market, By Product (Standalone Anesthesia Machines, Portable Anesthesia Machines, Vaporizers, and Others), By Animal Type (Small and Large), By End-Use, and By Region Forecast to 2032

Lyme Disease Treatment Market, By Treatment Type (Medication and Tick Removal), By Administration Route (Oral, Injectable, and Topical), By Distribution Channel (Hospital, Retail, and Online), By Application, and By Region Forecast to 2032

Animal Microchip Implant Market, By Product Type (Animal ID Microchip, Reusable Pet Tracking Microchip, Transponder Microchips, Others), By Mode (Self-injectable, Surgery-injectable), By End-use, By Region Forecast to 2032

Contrast Media Market, By Modality [Computed Topography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound], By Application [Cardiovascular Disorders (CVD), Neurological Disorders, and Cancer], and By Region Forecast to 2032

Polyacrylic Acid Market, By Type (CoPolymer, HomoPolymer, and TerPolymer), By Grade (Industrial Grade, Cosmetic Grade, and Pharmaceutical Grade), By Physical State, By Application, By End-Use, and By Region Forecast to 2032

Flocculants Market, By Type (Synthetic Flocculants, Natural Flocculants, and Mineral Flocculants), By Category (Anionic, Cationic, Non-Ionic, and Others), By End-Use (Wastewater Treatment, Textile, and Paper), and By Region Forecast to 2032

Smart Television Market, By Operating System (Android TV, Tizen, Roku, WebOS, Others), By Resolution (4K UHD TV, HDTV, Full HD, 8K TV), By Screen Size, By Screen Type (Flat, Curved) By Region Forecast to 2032

Industrial Automation Market, By Component (Hardware, Software, Services), By Industry Vertical (Oil & Gas, Manufacturing, Automotive, Healthcare, Energy & Power, Others) By Region Forecast to 2032

Automotive Charge Air Cooler Market, By Vehicle Type (Light Commercial Vehicle, Heavy Commercial Vehicle, and Others), By Product Type (Liquid-Cooled and Air-Cooled), By Position, By Fuel Type, By Design, and By Region Forecast to 2032

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research Media Citations: https://www.emergenresearch.com/media-citations

Visit for More Insights: https://www.emergenresearch.com/insights

Press Release: https://www.emergenresearch.com/press-release/global-allergy-diagnostics-market

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.